As of January 2025, Vcanbio Cell & Gene Engineering Corp. has a market cap of $1.27B. This makes Vcanbio Cell & Gene Engineering Corp. the world's 6727th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $1.01B | -22.20% |
2023 | $1.30B | 19.17% |
2022 | $1.09B | -32.61% |
2021 | $1.62B | 28.71% |
2020 | $1.26B | 15.83% |
2019 | $1.09B | 4.25% |
2018 | $1.04B | -42.82% |
2017 | $1.82B | 5.97% |
2016 | $1.72B | -58.78% |
2015 | $4.17B | 60.48% |
2014 | $2.60B | 69.07% |
2013 | $1.54B | 33.56% |
2012 | $1.15B | -21.28% |
2011 | $1.46B | 142.96% |
2010 | $601.61M | 24.57% |
2009 | $482.96M | 93.08% |
2008 | $250.14M | -50.57% |
2007 | $506.05M | 206.63% |
2006 | $165.04M | 49.66% |
2005 | $110.28M | -25.13% |
2004 | $147.29M | -70.25% |
2003 | $495.11M | -19.77% |
2002 | $617.09M | 11.61% |
2001 | $552.89M | 5.28% |
2000 | $525.18M | 98.66% |
1999 | $264.36M | 13.59% |
1998 | $232.73M | 16.55% |
1997 | $199.69M | 36.11% |
1996 | $146.71M | -4.00% |
1995 | $152.82M | -39.56% |
1994 | $252.83M | 57.64% |
1993 | $160.38M | - |